| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Shirley K. Knauer | Q38317779 |
| P2860 | cites work | Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? | Q22251049 |
| PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis | Q24553314 | ||
| Estrogen receptors and human disease | Q24645374 | ||
| Peroxisome proliferator-activated receptor gamma and cancers | Q28204283 | ||
| Biology of PPAR gamma in cancer: a critical review on existing lacunae | Q28250687 | ||
| Cancer genes and the pathways they control | Q28275089 | ||
| Overview of nomenclature of nuclear receptors | Q28276106 | ||
| International Union of Pharmacology. LX. Retinoic acid receptors | Q28276127 | ||
| International Union of Pharmacology. LXIV. Estrogen receptors | Q28276169 | ||
| Principles for modulation of the nuclear receptor superfamily | Q28291197 | ||
| Cancer cell metabolism: Warburg and beyond | Q28293198 | ||
| Tumor cell metabolism: cancer's Achilles' heel | Q29619809 | ||
| Retinoic acid receptors and cancers. | Q30341794 | ||
| Advances in the development of retinoids as chemopreventive agents | Q33866243 | ||
| Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis | Q34313734 | ||
| Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia | Q34468570 | ||
| Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas | Q34578434 | ||
| PPAR dual agonists: are they opening Pandora's Box? | Q34618271 | ||
| Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review). | Q34638390 | ||
| Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents. | Q35029444 | ||
| Nuclear receptors: integration of multiple signalling pathways through phosphorylation | Q35078424 | ||
| Retinoids as chemopreventive agents. | Q35131461 | ||
| Therapeutic potential of thiazolidinediones as anticancer agents | Q35594034 | ||
| Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease | Q35633275 | ||
| Digging deep into the pockets of orphan nuclear receptors: insights from structural studies. | Q35832645 | ||
| Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors | Q35940872 | ||
| Ligand control of coregulator recruitment to nuclear receptors | Q36041022 | ||
| Estrogen-receptor biology: continuing progress and therapeutic implications | Q36065443 | ||
| Controlling nuclear receptors: the circular logic of cofactor cycles | Q36163600 | ||
| The many faces of PPARgamma | Q36344625 | ||
| Peroxisome proliferator-activated receptor gamma in malignant diseases. | Q36358616 | ||
| Nuclear receptors and chromatin remodeling machinery | Q36638925 | ||
| Nuclear retinoic acid receptor beta as a tool in chemoprevention trials | Q36683481 | ||
| Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. | Q53463690 | ||
| A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours. | Q54439319 | ||
| Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer. | Q54568961 | ||
| Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas | Q57890923 | ||
| Human larynx expresses isoforms of the oestrogen receptor | Q71046801 | ||
| EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups | Q73911065 | ||
| Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus | Q80624748 | ||
| PPARgamma expression in breast cancer: clinical value and correlation with ERbeta | Q81288974 | ||
| Head and neck cancers | Q81763215 | ||
| Head and neck cancer: recent advances and new standards of care | Q83955052 | ||
| Chemical biology of steroid and nuclear hormone receptors | Q36692265 | ||
| Chemoprevention of squamous cell carcinoma of the head and neck | Q36783789 | ||
| Guiding ligands to nuclear receptors | Q36826316 | ||
| Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential | Q36873161 | ||
| The tumor microenvironment and its role in promoting tumor growth | Q36946019 | ||
| RAR and RXR modulation in cancer and metabolic disease | Q36956230 | ||
| PPAR-delta in Vascular Pathophysiology | Q37037802 | ||
| Systemic therapies for recurrent and/or metastatic salivary gland cancers | Q37118940 | ||
| A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update | Q37129530 | ||
| Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer | Q37144740 | ||
| PPAR Ligands for Cancer Chemoprevention | Q37165190 | ||
| Chemotherapy in the treatment of locally advanced head and neck cancer | Q37169231 | ||
| PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors? | Q37185147 | ||
| The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis | Q37260716 | ||
| Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function | Q38354033 | ||
| Coactivator-mediated estrogen response in human squamous cell carcinoma lines | Q40151225 | ||
| Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma | Q40159954 | ||
| Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling | Q40181695 | ||
| Thyroid hormone receptor beta mutations in the 'hot-spot region' are rare events in thyroid carcinomas | Q40185310 | ||
| Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling | Q40372875 | ||
| Critical role of peroxisome proliferator-activated receptor gamma on anoikis and invasion of squamous cell carcinoma | Q40414414 | ||
| Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. | Q40579956 | ||
| Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gamma | Q40633862 | ||
| Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells | Q40783553 | ||
| Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. | Q40793790 | ||
| Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells | Q40891228 | ||
| Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line. | Q41151059 | ||
| Peroxisome proliferator-activated receptor gamma expression correlates with the differentiation level of normal, premalignant, and malignant laryngeal squamous cells. | Q42520815 | ||
| Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma | Q43757113 | ||
| Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. | Q44106113 | ||
| A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer. | Q46035584 | ||
| A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice. | Q46246626 | ||
| Estrogen and progesterone receptors in esophageal carcinoma | Q46598129 | ||
| Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: relationship with cell cycle regulators | Q46701858 | ||
| Metastasis of squamous cell carcinoma of the oral tongue is associated with down-regulation of epidermal fatty acid binding protein (E-FABP). | Q48086903 | ||
| Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets | Q48371695 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 349205 | |
| P577 | publication date | 2009-09-24 | |
| P1433 | published in | Journal of oncology | Q26853876 |
| P1476 | title | Prognostic and therapeutic potential of nuclear receptors in head and neck squamous cell carcinomas | |
| P478 | volume | 2009 |
| Q34669361 | The complexities of obesity and diabetes with the development and progression of pancreatic cancer | cites work | P2860 |
Search more.